REVENUES (Tables)

9 Months Ended

Sep. 30, 2024

REVENUES

Schedule of operating lease revenue

	Third Quarter Ended				Nine Months Ended
	September 30				September 30
(millions)	2024		2023		2024		2023
Operating lease revenue*		$133.5		$128.4		$398.3		$383.5

Schedule of principal activities, separated by reportable segments and geographic region

Net sales at public exchange rates by reportable segment are as follows:

	Third Quarter Ended				Nine Months Ended
	September 30				September 30
(millions)	2024		2023		2024		2023
Global Industrial
Product and sold equipment		$1,722.0		$1,710.1		$5,037.2		$4,985.5
Service and lease equipment		244.7		235.0		705.2		678.2
Global Institutional & Specialty
Product and sold equipment		1,133.2		1,071.7		3,264.5		3,039.7
Service and lease equipment		261.0		241.3		760.3		674.3
Global Healthcare & Life Sciences
Product and sold equipment		300.8		378.4		1,013.9		1,094.9
Service and lease equipment		29.6		27.8		86.1		81.8
Global Pest Elimination
Product and sold equipment		-		-		-		-
Service and lease equipment		307.2		283.1		869.0		795.5
Corporate
Product and sold equipment		-		10.7		-		31.9
Service and lease equipment		-		-		-		-
Total
Total product and sold equipment		$3,156.0		$3,170.9		$9,315.6		$9,152.0
Total service and lease equipment		$842.5		$787.2		$2,420.6		$2,229.8

Net sales at public exchange rates by geographic region for the third quarter ended September 30 are as follows:

	Global				Global Institutional				Global Healthcare				Global Pest
	Industrial				& Specialty				& Life Sciences				Elimination				Corporate
	2024		2023		2024		2023		2024		2023		2024		2023		2024		2023
United States		$844.3		$822.2		$970.9		$902.9		$102.0		$168.4		$217.2		$197.9		$-		$9.6
Europe		429.4		423.0		185.7		183.8		172.1		186.6		47.0		44.1		-		0.7
Asia Pacific		231.4		233.5		59.3		58.3		26.6		25.1		8.0		7.2		-		0.1
Latin America		194.8		193.7		47.8		49.4		6.5		6.8		14.8		14.9		-		0.3
Greater China		99.7		98.3		44.8		40.9		14.8		11.5		15.3		14.5		-		-
India, Middle East and Africa		112.0		117.5		20.7		17.1		7.1		5.8		1.8		1.6		-		-
Canada		55.1		56.9		65.0		60.6		1.3		2.0		3.1		2.9		-		-
Total		$1,966.7		$1,945.1		$1,394.2		$1,313.0		$330.4		$406.2		$307.2		$283.1		$-		$10.7

Net sales at public exchange rates by geographic region for the nine months ended September 30 are as follows:

	Global				Global Institutional				Global Healthcare				Global Pest
	Industrial				& Specialty				& Life Sciences				Elimination				Corporate
(millions)	2024		2023		2024		2023		2024		2023		2024		2023		2024		2023
United States		$2,468.4		$2,421.2		$2,815.0		$2,568.7		$399.4		$485.5		$605.7		$549.7		$-		$28.8
Europe		1,214.6		1,214.7		525.5		505.0		543.6		547.2		136.6		125.6		-		2.1
Asia Pacific		692.9		700.8		178.1		173.5		76.5		67.2		23.6		21.3		-		0.2
Latin America		582.0		534.8		144.5		138.3		17.9		19.1		44.3		42.7		-		0.8
Greater China		297.9		299.6		130.0		117.0		38.0		35.2		44.9		43.0		-		-
India, Middle East and Africa		323.5		329.7		54.0		49.0		19.6		17.5		5.2		5.2		-		-
Canada		163.1		162.9		177.7		162.5		5.0		5.0		8.7		8.0		-		-
Total		$5,742.4		$5,663.7		$4,024.8		$3,714.0		$1,100.0		$1,176.7		$869.0		$795.5		$-		$31.9

Summarized activity in the allowance for doubtful accounts

	Nine Months Ended
	September 30
(millions)	2024		2023
Beginning balance		$77.3		$71.9
Bad debt expense		33.2		44.2
Write-offs		(34.4)		(32.6)
Other (a)		(0.1)		(0.8)
Ending balance		$76.0		$82.7

(a) Other amounts are primarily the effects of changes in currency translations.

Schedule of contract liability

	Nine Months Ended
	September 30
(millions)	2024		2023
Contract liability as of beginning of the year		$110.9		$116.5
Revenue recognized in the period from:
Amounts included in the contract liability at the beginning of the year		(110.9)		(116.5)
Increases due to billings excluding amounts recognized as revenue during the period ended		103.9		105.5
Contract liability as of end of period		$103.9		$105.5